HOLD at 2% core; No add at $345.80 upper Bollinger with volume deficit; staged re-engagement at $326/$315-320 with breakout confirmation
HOLD at 2% portfolio weight. No trim, no add at $345.80. First add at $326 (10 EMA). Second add at $315-320 (refined). Third add on confirmed close >$356 with volume >8M. Stop $300 on volume. Buy 3-6 month $300 puts at 4-5% of position. PT $380 (6-9 months); $400-440 stretch on breakout.
| Position | Action |
|---|---|
| At $345.80 (2.9% gap to upper Bollinger Band $355.91, declining volume 8.70M → 6.05M) | Hold core position; NO add |
| Price pullback to $326 (10 EMA) | First add tranche (1/3 of target allocation) - ~6% margin of safety |
| Price pullback to $315-320 | Second add tranche (1/3 of target allocation) - wider staging in confirmed uptrend |
| Confirmed close >$356 with volume >8M | Third add tranche (1/3 of target allocation) - breakout confirmation required |
| Distribution signals: negative MACD divergence, >15M shares on red sessions, close below 10 EMA on volume with MACD histogram turning negative, failed retest of $356 on distribution, or post-earnings re-pricing | Trim 20-25% per 9/22 framework (upper-third trim into binary catalyst with distribution confirmed) |
| Close <$300 on expanding volume | Hard exit - structural break; warrants Underweight or full exit |
LRCX is in the early-to-middle innings of a structural AI infrastructure capex supercycle, delivering accelerating revenue growth (23%+), margin expansion, and 100%+ EPS growth at a reasonable 29.4x forward PE—making any weakness to the 50 SMA a high-probability entry point for a BUY rating.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 275.53 | bullish |
| close_50_sma | 306.60 | bullish |
| close_10_ema | 326.25 | bullish |
| rsi | 66.67 | neutral |
| macd | +9.40 | bullish |
| macd_signal | +3.00 | bullish |
| macd_histogram | +6.40 | bullish |
| boll_middle | 307.16 | neutral |
| boll_upper | 355.91 | bearish |
| boll_lower | 258.41 | bullish |
| atr | 13.52 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price at $326 (10 EMA)
Then: Add 1/3 of staged allocation
Forward PE of 29.4x is reasonable, not stretched at 60x trailing
↩ rebuts: “Bear waving 60x trailing PE as a smoking gun”
· concedes: Buying the upper Bollinger Band is poor risk management — wait for pullback to 10 EMA at $326 or breakout above $356; The 50 SMA at $306 is positioned to absorb pullbacks if the 200-day MA test materializes
LRCX is a cycle peak investment with deteriorating cash flow, parabolic technicals, and unpriced China binary risk—making it a SELL at current levels.
· concedes: LRCX is a great company
→ vs conservative: Flagging $1.96B working capital drag from receivables as a red flag completely misses that a 58% receivables increase signals an exploding order book and demand strength, not weakness; discipline that costs 15-20% of upside is expensive patience
→ vs conservative: Treating Bollinger Band at $355.91 as a wall while ignoring that a confirmed close above triggers a textbook breakout to $370-380; waiting for pullback to $326 risks missing a 10% move higher to save 3% on entry
→ vs conservative: Using word 'parabolic' mischaracterizes a structural V-shaped recovery from healthy 200 SMA pullback as momentum mania
→ vs conservative: Treating LRCX as a cyclical requiring 15x earnings entry misses that 50%+ market share in plasma etch and increasing etch intensity at each node transition (3nm, 2nm, A14) creates a structurally higher earnings plateau
→ vs conservative: Polymarket AI-chip export licensing at 33% and export-control chip security at 26% (combined ~50% probability) already largely priced in after stock sold off from $438 to $265
→ vs neutral: Declining volume from 8.70M to 6.05M is healthy digestion after breakout above $340, not a cautionary sign; surging volume with stalled price would be distribution
→ vs neutral: Has completely fumbled the macro tape by missing that 96% probability of no Fed rate cuts in 2026 means market has priced in dovish policy; weak September jobs print ensures Fed stays on hold, bullish for high-multiple growth names with duration-friendly characteristics
→ vs conservative: Bearish case requires believing AI capex reverses, etch duopoly gets disrupted, forward EPS estimates are wrong, AND technical breakout above $340 fails—all simultaneously to justify the cautious stance
| vwma | 306.34 | bullish |
| volume | 6.05M | neutral |
Support: 275.53 · 306.6 · 326.25 | Resistance: 340.1 · 355.91 · 370 · 380
The technical picture is constructively bullish but late-stage within the recent swing, with the long-term uptrend intact, a bullish moving-average stack (Price > 10 EMA > 50 SMA > 200 SMA), expanding MACD momentum, and RSI in a healthy range (not overbought). Price is near the Bollinger upper band ($355.91), suggesting short-term resistance, and the latest session showed a slight pullback on below-average volume. This is a trend-following environment, but new entries are best scaled on pullbacks to the 10 EMA rather than chasing the upper band. The FINAL TRANSACTION PROPOSAL is HOLD (trend intact; wait for a pullback to add or a breakout to scale in).
Market Cap
$432.74B
Beta
1.854
52-Week High
$438.50
52-Week Low
$131.02
50-Day MA
$306.05
200-Day MA
$275.07
Dividend Yield
0.38%
PE (TTM)
60.03x
Forward PE
29.39x
PEG Ratio
1.62
Price/Book
34.69x
Revenue (FY2026)
$23.23B
Revenue Growth (FY26 YoY)
+26.0%
EPS Growth (FY26 YoY)
+38.8%
Net Income Growth (FY26 YoY)
+35.6%
Net Income (FY2026)
$7.27B
EBITDA (FY2026)
$8.86B
EPS (TTM)
$5.76
Forward EPS
$11.76
Gross Margin (FY26)
50.5%
Operating Margin (FY26)
35.3%
Net Margin (FY26)
31.3%
ROE
65.07%
ROA
22.84%
Total Assets
$23.53B
Cash & Equivalents
$5.58B
Total Debt
$3.73B
Net Cash
$1.85B
Current Ratio
2.63x
Operating Cash Flow (FY26)
$5.86B
Free Cash Flow (FY26)
$4.89B
CapEx (FY26)
$0.97B
Dividends Paid (FY26)
$1.27B
Buybacks (FY26)
$3.85B
Total Capital Returns (FY26)
$5.12B
Strengths
Concerns
Lam Research delivered FY2026 revenue of $23.23B (+26.0% YoY) and net income of $7.27B (+35.6%), with margins expanding to 50.5% gross and 35.3% operating as the company benefits from AI capex supercycle demand. The balance sheet remains pristine with net cash of $1.85B and a 2.63x current ratio, while capital allocation prioritizes buybacks ($3.85B in FY26) over dividends. With consensus expecting Forward EPS of $11.76 (~104% growth) and a forward PE of 29.39x, the stock is rated HOLD due to valuation concerns at 90%+ of 52-week highs, with new entrants advised to await pullbacks toward ~$275.
Macro: Fed holds rates steady (96% no cuts, $8.8M Polymarket volume); Weak September jobs report triggers dovish repricing; U.S. recession probability 8% (UK 7%, Japan 4%); Nasdaq at fresh highs while Dow/small caps lag (bullish for tech beta); Disinflation confirmed by gold/silver rally; Bipartisan traction on China-bound chip tool restrictions (AI export licensing 33%, chip security 26%); No FRED macro data available (API key not configured).